Get App
Download App Scanner
Scan to Download
Advertisement
This Article is From Feb 05, 2022

Shree Cement, Siemens, Alkem Labs, Birla Corp, Lupin And More Q3 Reviews: HDFC Securities

Shree Cement, Siemens, Alkem Labs, Birla Corp And More Q3 Reviews: HDFC Securities

Shree Cement, Siemens, Alkem Labs, Birla Corp, Lupin And More Q3 Reviews: HDFC Securities
Visitors look at electronic boards displaying stock prices. (Photographer: Junko Kimura/Bloomberg)

BQ Blue's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer BloombergQuint's subscribers an opportunity to expand their understanding of companies, sectors and the economy.

HDFC Securities Institutional Equities

Shree Cement Ltd. - Shree Cement delivered strong margin despite both demand and cost headwinds. The company's Q3 FY22 standalone volume/Ebitda/adjusted profit after tax fell 9/24/21% YoY on account of weak demand, supply disruption from the Chhattisgarh plant, and elevated power costs.

Siemens India Ltd. - Siemens delivered Q1 FY22 revenue of Rs 32.4 billion (beat of 4.4%), impacted marginally by Covid-19 and disruption in supply chain caused by global semi-conductor shortage. Ebitda/adjusted profit after tax missed the estimate by 11.3/10.9% respectively, on account of higher commodity prices and lower forex gains.

Alkem Laboratories Ltd. - Alkem Labs' Q3 revenue/Ebitda beat our estimates by 2%/18%, led by good growth in India and international markets. It expects to outperform the Indian pharma market in the medium term.

Birla Corporation Ltd. - Poor demand and pricing mainly in the east along with rising fuel prices led to a consolidated decline of 6/2/39/64% YoY in volume/revenue/Ebitda/adjusted profit after tax for Birla Corp. Demand picked up in Q4, also aiding cost pass thorough capabilities.

Lupin Ltd. - Lupin's Q3 revenue/Ebitda missed our estimates by 1%/22%, primarily due to pressure on gross margin and higher research and development spends. Adjusted Ebitda margin dipped to 12.7%, the lowest in the past seven quarters.

Click on the attachment to read the full report:

DISCLAIMER

This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search
Add NDTV Profit As Google Preferred Source